Reference
1. Hooker AB, Lemmers M, Thurkow AL, et al. Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome. Hum Reprod Update. 2014;20(2):262-278.
2. Johary J, Xue M, Zhu X, Xu D, Velu PP. Efficacy of estrogen therapy in patients with intrauterine adhesions: systematic review. J Minim Invasive Gynecol. 2014;21(1):44-54.
3. Bosteels J, Weyers S, Mol BW, D’Hooghe T. Anti-adhesion barrier gels following operative hysteroscopy for treating female infertility: a systematic review and meta-analysis. Gynecol Surg.2014;11:113-127.
4. Deans R, Abbott J. Review of intrauterine adhesions. J Minim Invasive Gynecol. 2010;17(5):555-569.
5. Schenker JG, Margalioth EJ. Intrauterine adhesions: an updated appraisal. Fertil Steril. 1982;37(5):593-610.
6. Schenker JG. Etiology of and therapeutic approach to synechia uteri.Eur J Obstet Gynecol Reprod Biol. 1996;65(1):109-113.
7. Asherman JG. Traumatic intra-uterine adhesions. J Obstet Gynaecol Br Emp. 1950;57(6):892-896.
8. March CM. Management of Asherman’s syndrome. Reprod Biomed Online. 2011;23(1):63-76.
9. Kou L, Jiang X, Xiao S, Zhao YZ, Yao Q, Chen R. Therapeutic options and drug delivery strategies for the prevention of intrauterine adhesions. J Control Release. 2020;318:25-37.
10. Thomson AJ, Abbott JA, Kingston A, Lenart M, Vancaillie TG. Fluoroscopically guided synechiolysis for patients with Asherman’s syndrome: menstrual and fertility outcomes. Fertil Steril.2007;87(2):405-410.
11. Hanstede MMF, van der Meij E, Veersema S, Emanuel MH. Live births after Asherman syndrome treatment. Fertil Steril.2021;116(4):1181-1187.
12. Deans R, Vancaillie T, Ledger W, Liu J, Abbott JA. Live birth rate and obstetric complications following the hysteroscopic management of intrauterine adhesions including Asherman syndrome. Hum Reprod.2018;33(10):1847-1853.
13. Chen L, Zhang H, Wang Q, et al. Reproductive Outcomes in Patients With Intrauterine Adhesions Following Hysteroscopic Adhesiolysis: Experience From the Largest Women’s Hospital in China. J Minim Invasive Gynecol. 2017;24(2):299-304.
14. Hooker AB, de Leeuw RA, Twisk JWR, Brolmann HAM, Huirne JAF. Reproductive performance of women with and without intrauterine adhesions following recurrent dilatation and curettage for miscarriage: long-term follow-up of a randomized controlled trial. Hum Reprod.2021;36(1):70-81.
15. Hooker AB, Mansvelder FJ, Elbers RG, Frijmersum Z. Reproductive outcomes in women with mild intrauterine adhesions; a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2021:1-9.
16. Hanstede MM, van der Meij E, Goedemans L, Emanuel MH. Results of centralized Asherman surgery, 2003-2013. Fertil Steril.2015;104(6):1561-1568 e1561.
17. Roy KK, Baruah J, Sharma JB, Kumar S, Kachawa G, Singh N. Reproductive outcome following hysteroscopic adhesiolysis in patients with infertility due to Asherman’s syndrome. Arch Gynecol Obstet.2010;281(2):355-361.
18. Valle RF, Sciarra JJ. Intrauterine adhesions: hysteroscopic diagnosis, classification, treatment, and reproductive outcome. Am J Obstet Gynecol. 1988;158(6 Pt 1):1459-1470.
19. Zikopoulos KA, Kolibianakis EM, Platteau P, et al. Live delivery rates in subfertile women with Asherman’s syndrome after hysteroscopic adhesiolysis using the resectoscope or the Versapoint system.Reprod Biomed Online. 2004;8(6):720-725.
20. Chen L, Xiao S, He S, Tian Q, Xue M. Factors That Impact Fertility after Hysteroscopic Adhesiolysis for Intrauterine Adhesions and Amenorrhea: A Retrospective Cohort Study. J Minim Invasive Gynecol. 2020;27(1):54-59.
21. Morales B, Movilla P, Wang J, et al. Patient-reported menstrual and obstetric outcomes following hysteroscopic adhesiolysis for Asherman syndrome. F S Rep. 2021;2(1):118-125.
22. Feng Q, Gao B, Huang H, et al. Obstetrical outcome in the third trimester after hysteroscopic adhesiolysis. Ann Transl Med.2020;8(4):51.
23. Zhang Y, Zhu X, Zhang T, Zhang Y, Zhang M, Lin X. Analysis of risk factors for obstetric outcomes after hysteroscopic adhesiolysis for Asherman syndrome: A retrospective cohort study. Int J Gynaecol Obstet. 2022;156(1):89-94.
24. Zhang LP, Wang M, Shang X, et al. The incidence of placenta related disease after the hysteroscopic adhesiolysis in patients with intrauterine adhesions. Taiwan J Obstet Gynecol.2020;59(4):575-579.
25. Baradwan S, Baradwan A, Bashir M, Al-Jaroudi D. The birth weight in pregnant women with Asherman syndrome compared to normal intrauterine cavity: A case-control study. Medicine (Baltimore).2018;97(32):e11797.
26. International Association of D, Pregnancy Study Groups Consensus P, Metzger BE, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676-682.
27. Stepan H, Kuse-Fohl S, Klockenbusch W, et al. Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013). Geburtshilfe Frauenheilkd. 2015;75(9):900-914.
28. Obstetrics Subgroup CSoO, Gynecology CMA. [Guidelines for diagnosis and treatment of intrahepatic cholestasis of pregnancy (2015)]. Zhonghua Fu Chan Ke Za Zhi. 2015;50(7):481-485.
29. Obstetrics Subgroup CSoO, Gynecology CMA, Obstetrics Subgroup Chinese Society of O, Gynecology Chinese Medical A. [Guideline of prevention and treatment about postpartum hemorrhage (2014)].Zhonghua Fu Chan Ke Za Zhi. 2014;49(9):641-646.
30. Quinn JA, Munoz FM, Gonik B, et al. Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine. 2016;34(49):6047-6056.
31. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75-84.
32. American College of O, Gynecologists’ Committee on Practice B-O. Prediction and Prevention of Spontaneous Preterm Birth: ACOG Practice Bulletin, Number 234. Obstet Gynecol. 2021;138(2):e65-e90.
33. ACOG Practice Bulletin No.142: Cerclage for the management of cervical insufficiency. Obstet Gynecol. 2014;123(2 Pt 1):372-379.
34. Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: Pathophysiology, Challenges, and Perspectives. Circ Res.2019;124(7):1094-1112.
35. Di Guardo F, Palumbo M. Asherman syndrome and insufficient endometrial thickness: A hypothesis of integrated approach to restore the endometrium. Med Hypotheses. 2020;134:109521.
36. Rabaglino MB, Post Uiterweer ED, Jeyabalan A, Hogge WA, Conrad KP. Bioinformatics approach reveals evidence for impaired endometrial maturation before and during early pregnancy in women who developed preeclampsia. Hypertension. 2015;65(2):421-429.
37. Garrido-Gomez T, Dominguez F, Quinonero A, et al. Defective decidualization during and after severe preeclampsia reveals a possible maternal contribution to the etiology. Proc Natl Acad Sci U S A.2017;114(40):E8468-E8477.
38. Ng SW, Norwitz GA, Pavlicev M, Tilburgs T, Simon C, Norwitz ER. Endometrial Decidualization: The Primary Driver of Pregnancy Health.Int J Mol Sci. 2020;21(11).
39. Silver RM, Branch DW. Placenta Accreta Spectrum. N Engl J Med. 2018;378(16):1529-1536.
40. Khopkar U, Williams RM, Selinger M. Morbid adhesion of the placenta after hysteroscopic lysis of intrauterine adhesions. Fertil Steril. 2006;86(5):1513 e1511-1513.
41. Engelbrechtsen L, Langhoff-Roos J, Kjer JJ, Istre O. Placenta accreta: adherent placenta due to Asherman syndrome. Clin Case Rep. 2015;3(3):175-178.
42. Tantbirojn P, Crum CP, Parast MM. Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast. Placenta.2008;29(7):639-645.
43. Murphy VE, Smith R, Giles WB, Clifton VL. Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus.Endocr Rev. 2006;27(2):141-169.
44. Carter AM. Evolution of placental function in mammals: the molecular basis of gas and nutrient transfer, hormone secretion, and immune responses. Physiol Rev. 2012;92(4):1543-1576.
45. Donders GG, Van Calsteren K, Bellen G, et al. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG.2009;116(10):1315-1324.
46. Manns-James L. Bacterial vaginosis and preterm birth. J Midwifery Womens Health. 2011;56(6):575-583.
47. Gravett MG, Nelson HP, DeRouen T, Critchlow C, Eschenbach DA, Holmes KK. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA.1986;256(14):1899-1903.
48. Odibo AO, Talucci M, Berghella V. Prediction of preterm premature rupture of membranes by transvaginal ultrasound features and risk factors in a high-risk population. Ultrasound Obstet Gynecol.2002;20(3):245-251.
49. Liu Z, Kong Y, Gao Y, et al. Revealing the interaction between intrauterine adhesion and vaginal microbiota using highthroughput sequencing. Mol Med Rep. 2019;19(5):4167-4174.
50. Peebles K, Kiweewa FM, Palanee-Phillips T, et al. Elevated Risk of Bacterial Vaginosis Among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort Study. Clin Infect Dis.2021;73(3):513-520.
51. Merki-Feld GS, Lebeda E, Hogg B, Keller PJ. The incidence of actinomyces-like organisms in Papanicolaou-stained smears of copper- and levonorgestrel-releasing intrauterine devices. Contraception.2000;61(6):365-368.
52. Chen C, Zhang JW, Xia HW, et al. Preterm Birth in China Between 2015 and 2016. Am J Public Health. 2019;109(11):1597-1604.